Vidac Pharma: Clinical Trials

2 trials sponsored by Vidac Pharma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Vidac Pharma: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Evaluate the Efficacy, Safety, and Tolerability of Topical VDA-1102 Ointment in Subjects With Actinic Keratosis
10% VDA-1102, 20% VDA-1102 - Actinic Keratosis
Phase 2CompletedVidac Pharma832018-05-232022-08-23
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis
Placebo, 5% VDA-1102, 10% VDA-1102 - Actinic Keratosis
Phase 2CompletedVidac Pharma932016-07-152023-01-12

Conditions studied

Keratosis, Actinic (2)  ·  Carcinoma, Squamous Cell (1)  ·  Precancerous Conditions (1)

Interventions

Excipients (1)

Countries

United States (2)

Top investigators

Chaim M Brickman, MD (1)  ·  Mark G Lebwohl, MD (1)